Archive: 04/04/2016
New syndrome named, causes a rare intellectual disability
Pediatric researchers, using high-speed DNA sequencing tools, have identified a new syndrome that causes intellectual disability (ID). Drawing on knowledge of the causative gene mutation, the scientists' cell studies suggest ...
Apr 4, 2016
Gilead paying up to $1.2B for Nimbus unit, drug candidate
Biologic drugmaker Gilead Sciences Inc. said Monday that it will buy a subsidiary of Nimbus Therapeutics LLC and its experimental pill for an increasingly common metabolic disorder that causes life-threatening fat buildup ...
Apr 4, 2016
Fentanyl patch prescribing still not safe in 50 percent of prescriptions
Although prescribing of the fentanyl patch has improved, physicians are still failing to adhere to safe prescribing guidelines, with half of new prescriptions being written for people who have not had the required previous ...
Apr 4, 2016
Efmoroctocog alfa for hemophilia A: Added benefit not proven
Efmoroctocog alfa (trade name: Elocta) has been approved since November 2015 for people with type A haemophilia. This is an inherited disorder that impairs blood clotting. The German Institute for Quality and Efficiency in ...
Apr 4, 2016
New app improves treatment of atrial fibrillation
Atrial fibrillation increases the risk of stroke. Treatment with oral anticoagulation reduces this risk but instead increases the risk of bleeding. Today, a new blood test based tool enabling better and more individualized ...
Apr 4, 2016
New study describes altered brain activity in response to desirable foods
Understanding the motivations that drive humans to eat is an important consideration in the development of weight loss therapies. Now a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) helps explain ...
Apr 4, 2016